ArticleESMO real world data and digital oncology2026
Digital health technology in oncology: results from a survey by the ESMO Young Oncologists Committee and medical student alumni.
Article in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Digital health technologies are transforming oncology care, yet adoption remains inconsistent globally. This study evaluates current utilization patterns, perceived effectiveness, and barriers among oncology professionals worldwide. Methods: We conducted a global cross-sectional survey (27 questions) analyzing workplace characteristics, technology usage patterns, effectiveness, and barriers to adoption among oncology professionals to better understand the real-world adoption of digital health technologies. Using a questionnaire developed by the ESMO Young Oncologists Committee in collaboration with the medical student alumni, we assessed device availability, technology usage, effectiveness ratings, training experiences, and implementation barriers. Responses were analyzed using descriptive statistical methods to identify usage patterns, variations and barriers to adoption of digital health technologies. Results: A total of 423 oncology professionals completed the questionnaire. The survey revealed widespread access to computerized workstations (89.1%) but notable geographic disparities (Africa 67.7% versus Europe 93.8%, Discussion: Findings from the present survey highlight persistent disparities in digital health adoption, emphasizing the need for infrastructure investment, interoperable systems, and tailored training to ensure equitable implementation and maximize the potential of technology in oncology care globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.